'High throughput' solid-phase extraction technology and turbo ionspray LC-MS-MS applied to the determination of haloperidol in human plasma.
A quantitative method for the analysis of haloperidol in human plasma is described. Sample clean-up was performed by means of solid-phase extraction using 3M Empore extraction disk plates in the 96-well format, automated with a Canberra Packard pipetting robot. Separation was performed by reversed phase high performance liquid chromatography with turbo ionspray tandem mass spectrometric detection by monitoring the decay of protonated haloperidol of m/z 376 to its fragment at m/z 165, versus the decay of protonated haloperidol-D4 at m/z 380 to its fragment at m/z 169. The validated concentration range was from 0.100 to 50.0 ng ml(-1), with an inaccuracy and overall imprecision below 10% at all concentration levels. Validation results on linearity, specificity, precision, accuracy and stability are shown and are found to be adequate. The average sample preparation time for a batch of 96 samples is approximately 50 min. The chromatographic run time is 3 min. A sample throughput of at least 240 samples per day can be achieved.
Hempenius
J
J
Pharma Bio-Research International B.V., Zuidlaren, The Netherlands.
Steenvoorden
R J
RJ
Lagerwerf
F M
FM
Wieling
J
J
Jonkman
J H
JH
D014150:Antipsychotic Agents / Q000097:blood*; D002853:Chromatography, Liquid; D019411:Clinical Laboratory Techniques / Q000295:instrumentation; D006220:Haloperidol / Q000097:blood*; D006801:Humans; D013058:Mass Spectrometry; D015203:Reproducibility of Results
D014150:Antipsychotic Agents; D006220:Haloperidol